Carret Asset Management’s Eli Lilly LLY Stock Holding History

Carret Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.46M	Sell	4,853 -50	-1%	-$50.7K	0.44%	60
2025 Q4	$5.27M	Sell	4,903 -140	-3%	-$134K	0.5%	55
2025 Q3	$3.85M	Sell	5,043 -210	-4%	-$156K	0.37%	66
2025 Q2	$4.09M	Sell	5,253 -5	-0.1%	-$3.88K	0.44%	60
2025 Q1	$4.34M	Buy	5,258 +36	+0.7%	+$30K	0.49%	55
2024 Q4	$4.03M	Sell	5,222 -250	-5%	-$207K	0.44%	59
2024 Q3	$4.85M	Sell	5,472 -560	-9%	-$503K	0.53%	55
2024 Q2	$5.46M	Sell	6,032 -142	-2%	-$114K	0.64%	46
2024 Q1	$4.8M	Sell	6,174 -390	-6%	-$278K	0.57%	50
2023 Q4	$3.83M	Buy	6,564 +7	+0.1%	+$4.09K	0.49%	56
2023 Q3	$3.52M	Sell	6,557 -600	-8%	-$309K	0.49%	58
2023 Q2	$3.36M	Buy	7,157 +40	+0.6%	+$16.8K	0.45%	62
2023 Q1	$2.44M	Sell	7,117 -50	-0.7%	-$16.9K	0.34%	78
2022 Q4	$2.62M	Hold	7,167	–	–	0.36%	74
2022 Q3	$2.32M	Sell	7,167 -100	-1%	-$31.7K	0.35%	78
2022 Q2	$2.36M	Buy	7,267 +15	+0.2%	+$4.5K	0.33%	82
2022 Q1	$2.08M	Hold	7,252	–	–	0.24%	98
2021 Q4	$2M	Hold	7,252	–	–	0.22%	102
2021 Q3	$1.68M	Sell	7,252 -400	-5%	-$98.7K	0.2%	115
2021 Q2	$1.76M	Hold	7,652	–	–	0.21%	111
2021 Q1	$1.43M	Hold	7,652	–	–	0.18%	120
2020 Q4	$1.29M	Hold	7,652	–	–	0.17%	122
2020 Q3	$1.13M	Sell	7,652 -98	-1%	-$15.2K	0.17%	116
2020 Q2	$1.27M	Hold	7,750	–	–	0.21%	105
2020 Q1	$1.07M	Sell	7,750 -81	-1%	-$11.1K	0.21%	100
2019 Q4	$1.03M	Hold	7,831	–	–	0.15%	129
2019 Q3	$876K	Hold	7,831	–	–	0.14%	136
2019 Q2	$868K	Sell	7,831 -119	-1%	-$14K	0.14%	134
2019 Q1	$1.03M	Buy	7,950 +100	+1%	+$12.2K	0.17%	120
2018 Q4	$908K	Hold	7,850	–	–	0.16%	118
2018 Q3	$842K	Hold	7,850	–	–	0.13%	142
2018 Q2	$670K	Hold	7,850	–	–	0.11%	147
2018 Q1	$607K	Hold	7,850	–	–	0.1%	157
2017 Q4	$663K	Hold	7,850	–	–	0.1%	154
2017 Q3	$671K	Sell	7,850 -100	-1%	-$8.2K	0.11%	150
2017 Q2	$654K	Sell	7,950 -50	-0.6%	-$4.08K	0.11%	149
2017 Q1	$673K	Sell	8,000 -200	-2%	-$16K	0.12%	137
2016 Q4	$603K	Buy	8,200 +2,575	+46%	+$192K	0.11%	143
2016 Q3	$451K	Buy	5,625 +125	+2%	+$10K	0.08%	161
2016 Q2	$433K	Hold	5,500	–	–	0.08%	163
2016 Q1	$396K	Hold	5,500	–	–	0.08%	164
2015 Q4	$463K	Hold	5,500	–	–	0.1%	157
2015 Q3	$460K	Hold	5,500	–	–	0.1%	158
2015 Q2	$459K	Sell	5,500 -135	-2%	-$10.3K	0.09%	167
2015 Q1	$409K	Hold	5,635	–	–	0.08%	174
2014 Q4	$389K	Hold	5,635	–	–	0.07%	184
2014 Q3	$365K	Hold	5,635	–	–	0.07%	194
2014 Q2	$350K	Buy	5,635 +1,935	+52%	+$115K	0.07%	199
2014 Q1	$218K	Buy	+3,700	New	+$206K	0.04%	238
2013 Q4	–	Sell	-4,150	Closed	-$209K	–	267
2013 Q3	$209K	Hold	4,150	–	–	0.05%	236
2013 Q2	$204K	Buy	+4,150	New	+$226K	0.04%	290

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carret Asset Management's LLY Position: Q1 2026 in Review

Carret Asset Management reduced its Eli Lilly (LLY) stake by 1% in Q1 2026, selling an estimated $50.7K and leaving 4,853 shares worth $4.46M. The position accounts for 0.44% of the portfolio, ranked #60.

Carret Asset Management first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.46M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Carret Asset Management held 4,853 shares of Eli Lilly worth $4.46M as of Q1 2026.
Carret Asset Management sold 50 Eli Lilly shares in Q1 2026, an estimated $50.7K.
Eli Lilly made up 0.44% of Carret Asset Management's portfolio in Q1 2026, its #60 holding.
Carret Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
Carret Asset Management's Eli Lilly position peaked at $5.46M in Q2 2024.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Carret Asset Management's 13F filing for Q1 2026, filed 15 May 2026.